Literature DB >> 8623787

Elevation of nitrate levels in pregnant ewes and their fetuses.

D Yang1, U Lang, S G Greenberg, L Myatt, K E Clark.   

Abstract

OBJECTIVE: Nitric oxide is a potent vasodilator released by endothelial cells that may play an important role in modulating maternal and fetal vascular tone in normal pregnancy. The current study was designed to evaluate whether plasma or urine nitrite and nitrate (the metabolites of nitric oxide) concentrations are elevated in pregnant compared with those of nonpregnant sheep and whether the nitrate concentrations in the fetal circulation were increased in comparison with the maternal circulation. STUDY
DESIGN: Eleven pregnant sheep and seven nonpregnant oophorectomized sheep were instrumented with catheters in the maternal and fetal femoral arteries and veins, uterine and umbilical veins, and amniotic cavity. Blood, urine, and amniotic fluid samples were collected for nitrate determination at least 5 days after surgery. After extraction nitrate was reduced to nitrite and quantitated with the Greiss reagent.
RESULTS: Arterial plasma nitrate concentrations in the pregnant sheep were significantly elevated compared with those of nonpregnant sheet (5.0 +/- 0.9 vs 2.5 +/- 0.6 micromol/L, p < 0.05). The urinary nitrate concentrations were also significantly increased in the pregnant sheep compared with those of nonpregnant sheet (89.9 +/- 16.3 vs 23.1 +/- 4.5 nmol/mg creatinine, p < 0.01). Fetal plasma nitrate concentrations were ninefold higher than the maternal nitrate concentrations (43.9 +/- 7 vs 5.0 +/- 0.9 micromol/L, p < 0.01), whereas amniotic fluid concentrations were extremely high (133.8 +/- 13.8 micromol/L, n = 3). No venous-arterial differences were measurable across either the maternal or fetal sides of the placenta.
CONCLUSION: Nitrate concentrations in pregnant sheet and their fetuses are increased. The increased nitrate concentrations in the maternal and fetal circulations may reflect the increased nitric oxide synthesis, which may in part mediate the cardiovascular adaptations to normal pregnancy and the low systemic and umbilical vascular resistance in the fetus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623787     DOI: 10.1016/s0002-9378(96)70430-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Effects of the Catechol and Methoxy Metabolites of 17β-Estradiol on Nitric Oxide Production by Ovine Uterine Artery Endothelial Cells.

Authors:  Rosalina Villalon Landeros; Mayra B Pastore; Ronald R Magness
Journal:  Reprod Sci       Date:  2018-06-21       Impact factor: 3.060

Review 2.  Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.

Authors:  Kirk P Conrad
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

Review 3.  Shear stress regulation of nitric oxide production in uterine and placental artery endothelial cells: experimental studies and hemodynamic models of shear stresses on endothelial cells.

Authors:  Benjamin Sprague; Naomi C Chesler; Ronald R Magness
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

4.  Increased nitrite reductase activity of fetal versus adult ovine hemoglobin.

Authors:  Arlin B Blood; Mauro Tiso; Shilpa T Verma; Jennifer Lo; Mahesh S Joshi; Ivan Azarov; Lawrence D Longo; Mark T Gladwin; Daniel B Kim-Shapiro; Gordon G Power
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-21       Impact factor: 4.733

5.  Endotoxin-induced cerebral pathophysiology: differences between fetus and newborn.

Authors:  Susan Y S Feng; Jacob H Hollis; Thilini Samarasinghe; David J Phillips; Shripada Rao; Victor Y H Yu; Adrian M Walker
Journal:  Physiol Rep       Date:  2019-02

6.  Nitric oxide synthase activity in human trophoblast, term placenta and pregnant myometrium.

Authors:  J Al-Hijji; Ellika Andolf; Ricardo Laurini; Satish Batra
Journal:  Reprod Biol Endocrinol       Date:  2003-06-28       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.